tirzepatide pris Reduces Food Intake and Appetite, and Affects Brain Functioning, more than a Placebo and Liraglutide Experience the Power of Tirzepatide:

Jan 28 2020;9(2)doi:10.3390/antiox9020116 Guo J, Hao X, Wang R, et al

You can discuss the benefits and risks and decide whether microdosing is a treatment option for your condition

While its safety profile was consistently favorable, the largest Phase IIb trial failed to show statistical significance for weight loss, and commercial development was halted in 2007.[2] Despite this, interest in AOD-9604 has continued in the compounding pharmacy and integrative medicine space, particularly given its safety data, its lack of IGF-1 stimulation, and emerging research around joint health

Vitamin A and/or antibiotics may also be prescribed